Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.

The global cell and gene therapy market is undergoing rapid expansion, driven by the surge in regulatory approvals and continual advancements in therapeutic technologies. The market is anticipated to ...

The latest in a trend of companies stepping back from cell and gene therapies amid regulatory uncertainty and manufacturing ...

Cell and gene therapies (CGTs) are moving rapidly from specialist trials to routine care: more than thirty products are ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

Ewha Womans University Blood Cancer Hospital (Hospital Director Moon Young-chul) recently opened a cell and gene processing ...

New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...

A one-time gene therapy using a patient’s own stem cells has effectively cured a deadly immune disorder in 95% of treated ...

The move aims to regulate cell and gene therapies, and xenografts or animal-to-human transplants. Such therapies are ...